Lathrop In the News
Boston Scientific Corporation entered into an agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation tools to better detect and treat abnormal heart beats, or cardiac arrhythmias. Rhythmia Medical, Inc. developed this innovative technology that measures the heart's electrical activity with support from a small business innovative research grant from the National Heart, Lung, and Blood Institute.
"The study provides us with more insight about how both genders of heart failure patients may be impacted by the obesity paradox," noted senior author Dr. Tamara Horwich, an assistant professor of cardiology at the David Geffen School of Medicine at UCLA. He added, "Heart failure may prove to be one of the few health conditions where extra weight may prove to be protective."
An international team of researchers discovered that a heart attack doesn't just damage heart muscle tissue by cutting off its blood supply, it also sets off an inflammatory response that worsens underlying atherosclerosis, actively increasing the risk for a future heart attack. Study results were published in the journal Nature.
Can coffee protect your heart? NHLBI-supported researchers at Beth Israel Deaconess Medical Center in Boston report that moderate coffee consumption (two 8-ounce cups per day) could be beneficial to the heart.
Study results from the NHLBI-supported Resuscitation Outcomes Consortium released today in the journal Circulation confirm that repeated chest compressions have improved the survival rate for cardiac arrest patients.
The first human study to link chest compressions to survival in cardiac-arrest patients, published Tuesday in the journal Circulation, found that return of spontaneous circulation rates peaked at a compression rate of 125 per minute and then declined, according to the study’s lead investigator, NHLBI-supported researcher Dr. Ahamed H. Idris (UT Southwestern Medical Center).
NHLBI-supported researchers Dr. Burns C. Blaxall (University of Rochester Medical Center) and Nigel Mackman (UNC McAllister Heart Institute at the University of North Carolina at Chapel Hill) discuss a new discovery published in the journal Circulation that could pack a powerful one-two punch in the fight against heart failure. The article talks about two potential drug targets that may hold promise for the treatment of heart disease.
Evolution has provided a number of animal species with extraordinary phenotypes. Several of these phenotypes allow species to survive and thrive in environmental conditions that mimic disease states in humans. The study of evolved mechanisms responsible for these phenotypes may provide insights into the basis of human disease and guide the design of new therapeutic approaches.
"Penn's inclusion in the national network is both an honor and a great opportunity to help develop new strategies for treating patients with heart failure," said Kenneth Margulies, M.D., professor of Medicine and co-principal investigator of the Penn Regional Center.